Category for reagents and intermediates used in the synthesis or analysis of PCSK9 inhibitors, which target proprotein convertase subtilisin/kexin type 9 to regulate cholesterol metabolism.
The availability date depends on real-time stock, and any changes after payment will be notified within 30 minutes
You can choose the delivery date on the next page